[The treatment of anemia due to iron-deficiency with iron combined with vitamins (author's transl)].
The effect of combined iron-vitamin therapy and iron therapy only was studied in 14 respectively 14 children with hypochromic anemia. Pyridoxalphosphate in serum, activity of red cell glutamic oxaloacetic transaminase and excretion of 4-pyridoxic acid were measured as indices of vitamin B6 nutriture before therapy was started, four and seven days under therapy once more. Erythrocytes, reticulocytes, concentration of hemoglobin were simultaneously counted, whereas serum iron and transferrin have been measured before and after therapy. A group of 22 hematologically healthy children was studied as controls. After iron therapy a decrease of vitamin B6 body pool came off as a consequence of increased requirement of pyridoxalphosphate for heme synthesis. Additional dosage of vitamins compensated the biochemical B6 deficit and had an accelerating effect on heme synthesis.
D000747:Anemia, Hypochromic / Q000188:drug therapy*; D002675:Child, Preschool; D004338:Drug Combinations; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007501:Iron / Q000627:therapeutic use*; D008297:Male; D011736:Pyridoxine / Q000627:therapeutic use; D012256:Riboflavin / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use*
D004338:Drug Combinations; D014815:Vitamins; D005492:Folic Acid; D007501:Iron; D011736:Pyridoxine; D014805:Vitamin B 12; D012256:Riboflavin
Die Behandlung der Eisenmangelanämie mit einem kombinierten Eisen-Vitamin-Präparat.